Advertisement
Legal/Regulatory
Subscribe to Legal/Regulatory

The Lead

New Approach to Delay Alzheimer's Onset to Be Tested

January 29, 2015 10:22 am | by Alzheimer's Drug Discovery Foundation | News | Comments

The Alzheimer's Drug Discovery Foundation (ADDF) announced a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. Read more...                       

Arizona Monitoring Hundreds for Measles Linked to Disneyland

January 29, 2015 10:03 am | by Felicia Fonseca, Associated Press | News | Comments

A measles outbreak in Arizona that originated at California's Disney parks is at risk of...

Atlas Genetics Completes $20M Series C Fundraising

January 29, 2015 8:54 am | News | Comments

Atlas develops ultra-rapid point-of-care diagnostic tests for infectious diseases. Read more......

Dr. Oz and the Weight Loss Claim Controversy

January 28, 2015 5:14 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A guest that has appeared on The Doctor Oz show was at the center of a lawsuit filed...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87 confirmed cases in people ranging in ages from 7 months to 70 years. Read more...                                     

Swiss Drug Maker Novartis Posts Q4 Profit Drop

January 28, 2015 12:04 pm | by Associated Press | News | Comments

Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit. Read more...                                 

IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

January 28, 2015 11:32 am | by IntelliCell BioSciences | News | Comments

IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company"), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced a license agreement for the indication of Diabetes Mellitus. Read more...

Advertisement

Donors Pledge Record $7.5B for Global Vaccines Program

January 28, 2015 8:40 am | by Associated Press | News | Comments

Governments and private donors have pledged a record $7.5 billion to replenish a global vaccination program for the poor. Read more...                     

Mylan Expands Hepatitis C Licensing Agreement with Gilead

January 26, 2015 11:18 am | by Associated Press | News | Comments

 Mylan Inc. announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir(Sovaldi)/GS-5816, once approved, in 91 developing countries. Read more...

WHO Adopts Reforms to Repair Reputation After Ebola

January 26, 2015 10:07 am | News | Comments

The World Health Organization has proposed reforms that could overhaul its structure after botching the response to the biggest-ever Ebola outbreak, a sluggish performance that experts say cost thousands of lives. Read more...                                    

FDA Approves Prestalia's Hypertension Treatment

January 26, 2015 10:00 am | by Prestalia | News | Comments

Symplmed Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Prestalia (perindopril arginine and amlodipine) tablets, licensed from Servier (Suresnes, France), for the treatment of hypertension.           

Added Protections for Consumer Info on Health Website

January 26, 2015 9:56 am | by Associated Press | News | Comments

The Obama administration appears to be making broader changes to protect consumer information on the government's health insurance website, after objections from lawmakers and privacy advocates. Read more...                 

Advertisement

Medical Pot Only OK for Sick Kids Failed by Other Drugs: MDS

January 26, 2015 9:52 am | by Lindsey Tanner, AP Medical Writer - Associated Press | News | Comments

With virtually no hard proof that medical marijuana benefits sick children, and evidence that it may harm developing brains, the drug should only be used for severely ill kids who have no other treatment option, the nation's most influential pediatricians group says in a new policy. Read more...

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

January 23, 2015 3:47 pm | News | Comments

The drug gained this designation in Europe. Read more...                                  

FDA Recommends Approval of Astellas' Fungal Infection Treatment

January 23, 2015 1:18 pm | News | Comments

The Advisory Committee's recommendation is based on data from the cresemba development program. Read more...                          

Measles Outbreak Casts Spotlight on Anti-Vaccine Movement

January 23, 2015 12:49 pm | by Alicia Chang - AP Science Writer | News | Comments

A major measles outbreak traced to Disneyland has brought criticism down on the small but vocal movement among parents to opt out of vaccinations for their children. Read more...              

Luoxis Establishes Initial European Distribution Network for Diagnostic System

January 23, 2015 9:15 am | by Luoxis | News | Comments

Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc.announced it has secured long-term agreements with European distributors Eurobio, Una Health Limited, and THP Medical, to offer Luoxis' RedoxSYS Diagnostic System to prominent academic and pharma-based research centers within their respective territories.  Read more...

Advertisement

Why are Generic Drugs Getting Pricy?

January 22, 2015 11:14 am | by The Conversation, Geoffrey Joyce | News | Comments

More than eight out of every 10 prescriptions dispensed in the U.S. is generic. This growth is because of a large number of top-selling drugs going off patent over the past decade, as well as innovations in the retail sector, such as Walmart’s $4 generic program.

World's Only Super-Database for Pharmaceutical Use During Pregnancy

January 22, 2015 9:50 am | by University of Montreal | News | Comments

Medical researchers must exclude pregnant women from drug trials to protect their babies. Read more...                           

Brittany Maynard Family Pushing California Right-to-Die Bill

January 21, 2015 12:15 pm | by Fent Nirappil - Associated Press | News | Comments

Three California lawmakers are promoting right-to-die legislation with the family of a terminally ill woman who moved to Oregon to legally end her life. Read more...                

Government Healthcare Website Quietly Sharing Personal Data

January 20, 2015 4:56 pm | by Ricardo Alonso-Zaldivar and Jack Gillum - Associated Press | News | Comments

The government's health insurance website is quietly passing along consumers' personal data to outside websites, just as President Barack Obama is calling for stronger cybersecurity protections. Read more...         

Supreme Court Sides With Teva in Drug Dispute

January 20, 2015 4:14 pm | by Sam Hananel - Associated Press | News | Comments

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug. Read more...           

Aetna Picks Gilead Sciences Hepatitis C Drugs Over Abbvie's

January 20, 2015 12:01 pm | by Associated Press | News | Comments

Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Read more...                                    

Container Closure Integrity: Testing at Low Temps

January 20, 2015 11:10 am | by Louis Brasten, Supervisor, Routine and Functional Analysis/Filling Services, Barbara Jacobs, Scientist, Analytical Services, Alicia Brydzinski, Scientist, Analytical Services - West Pharmaceutical Services, Inc. | Articles | Comments

The container closure integrity, or CCI, on packaging for parenteral drug products plays a critical role in the preservation of the drug product. The combination of the packaging closure components must be carefully selected to eliminate means of contamination that could affect the drug product negatively. Read more...

AbbVie's New Hepatitis C Treatment Gains European Approval

January 20, 2015 8:44 am | by Linda A. Johnson - AP Business Writer | News | Comments

The company said the European Commission granted marketing authorization for the combination of Viekirax and Exviera. Read more...                      

AbbVie Gains European Marketing Authorization for Hepatitis C Drugs

January 16, 2015 9:18 am | News | Comments

The approvals follow a review under accelerated assessment by the European Medicines Agency. Read more...                          

U.S. Painkiller Abuse 'Epidemic' May Be Declining: Study

January 15, 2015 10:35 am | News | Comments

The U.S. "epidemic" of prescription-painkiller abuse may be starting to reverse course, a new study suggests. Experts said the findings, published in the New England Journal of Medicine, are welcome news. The decline suggests that recent laws and prescribing guidelines aimed at preventing painkiller abuse are working to some degree. Read more...

Alimera Announces First Sale of Iluvien in Portugal

January 15, 2015 8:59 am | News | Comments

Alimera's medication is for the treatment of vision impairment associated with chronic diabetes. Read more...                         

Death Row Inmates Seek Appeal for Drug Protocol Ruling

January 14, 2015 12:47 pm | by Associated Press | News | Comments

Attorneys for four Oklahoma death row inmates are appealing to the U.S. Supreme Court to overturn a 10th Circuit Court ruling that approved the state's execution drug protocol. Read more...            

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading